Sichenzia Ross Ference represented Cyngn in the transaction. Cyngn Inc., a venture capital backed developer of innovative autonomous driving software solutions for industrial and commercial applications...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Sunshine Biopharma on the offering. Sunshine Biopharma, Inc., a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Relmada Therapeutics in the transaction. Relmada Therapeutics, Inc. (NASDAQ: “RLMD”), a late-stage biotechnology company, executed a $100 million At-The-Market offering facility (“ATM”)....
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Sharps Technology in the offering. Sharps Technology, Inc. (Nasdaq: STSS and STSSW), an innovative medical device company offering patented, best-in-class, single use...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference LLP represented Boustead Securities LLC in the Underwritten Public Offering for Genius Group Limited, assisted by Allen & Gledhill. Genius Group Limited announced...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Aegis Capital Corp. as sole book runner in the offering. Tantech Holdings Ltd (NASDAQ: TANH) executed its offering which included 20,000,000 shares of...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Sunshine Biopharma, Inc. Sunshine Biopharma, Inc., a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs (NASDAQ: SBFM),...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Splash Beverage Group in the transaction. Splash Beverage Group, Inc. (NYSE American: SBEV), a portfolio company of leading beverage brands, completed an underwritten public...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Sunshine Biopharma in the offering. Sunshine Biopharma, Inc. finalized an underwritten public offering. The offering consisted of 1,882,353 units at a price to the...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference advised Blue Star Helium Limited on the deal. Blue Star Helium Limited (OTCQB: “BSNLF”), an Australian helium exploration and development company, announced its listing...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Murphy Canyon Acquisition Corp. in the offering, while Manatt, Phelps & Phillips advised underwriters. Murphy Canyon Acquisition Corp. (Nasdaq: MURFU), a newly...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented Alset Capital Acquisition Corp. on the transaction. Ortoli Rosenstadt LLP acted for EF Hutton. Alset Capital Acquisition Corp. (Nasdaq: ACAXU), a newly...
You must be a Standard 1 Year member to access this content.
